Azetidine modulators of the sphingosine 1-phosphate receptor

作者: Chengzhi Zhang , Justin Chakma

DOI:

关键词:

摘要: Described are deuterium-substituted azetidine compounds of Formula (I), which modulators sphingosine 1 -phosphate receptor. Also described pharmaceutical compositions comprising the compounds, and methods use thereof.

参考文章(12)
Christian Schnell, Peter C. Hiestand, S1P receptor modulators for treating multiple sclerosis ,(2007)
Erik Wallstroem, Barbara Nuesslein-Hildesheim, David Leppert, Compounds for the treatment of peripheral neuropathies ,(2009)
Paul J Sheskey, Marian E Quinn, Raymond C Rowe, Handbook of Pharmaceutical Excipients ,(1994)
Caspar Vogel, Marilyn De La Cruz, Michael Mutz, Piotr H. Karpinski, Lech Ciszewski, Christian Riegert, Ricardo Schneeberger, Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acid ,(2009)
Yuan Mi, Nathanael Schiander Gray, Tao Jiang, Wenqi Gao, Shifeng Pan, Yi Fan, Immunosuppressant compounds and compositions ,(2004)
Syed Sohail Ahmed, Peter Gergely, Marco Londei, Timothy Wright, Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation ,(2009)
Eric Legangneux, Mike Ufer, Anne Gardin, Yi Jin, Hubert Borell, Identifying patient response to s1p receptor modulator administration ,(2013)
A. B. Foster, Deuterium isotope effects in the metabolism of drugs and xenobiotics: implications for drug design Advances in drug research. ,vol. 14, pp. 1- 40 ,(1985)